SCHEMBL6081707

SCHEMBL6081707

CCCCCCCC1CN1S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
KMT2A Q03164 1/20 0.44
GRM2 Q14416 1/20 0.44
MCOLN3 Q8TDD5 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MCHR1 Q99705 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MMP2 P08253 1/20 0.43
POLB P06746 1/20 0.42
PSEN1 P49768 1/20 0.41
PSEN2 P49810 1/20 0.41
APH1B Q8WW43 1/20 0.41
NCSTN Q92542 1/20 0.41
APH1A Q96BI3 1/20 0.41
PSENEN Q9NZ42 1/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
PKM P14618 1/20 0.41
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8472978 1.00 ALDH1A1 (0.44) ALDH1A1LMNAKMT2AGRM2MCOLN3
SCHEMBL28466754 1.00 ALDH1A1 (0.44) ALDH1A1LMNAKMT2AGRM2MCOLN3
SCHEMBL2600496 0.94 ALDH1A1 (0.46) ALDH1A1LMNAKMT2AMCOLN3L3MBTL1
SCHEMBL11991815 0.88 PSEN1 (0.51) ALDH1A1LMNAKMT2AMCOLN3L3MBTL1
SCHEMBL9877823 0.86 KMT2A (0.55) ALDH1A1LMNAKMT2ANPSR1POLB
SCHEMBL6526840 0.85 ALDH1A1 (0.57) ALDH1A1LMNAKMT2ANPSR1POLB
SCHEMBL29193737 0.84 MCOLN3 (0.40) ALDH1A1LMNAKMT2AMCOLN3L3MBTL1
SCHEMBL29266630 0.82 MCOLN3 (0.41) ALDH1A1LMNAKMT2AMCOLN3L3MBTL1
SCHEMBL6845965 0.82 ALDH1A1 (0.50) ALDH1A1LMNAKMT2AMCOLN3L3MBTL1
SCHEMBL6845966 0.82 ALDH1A1 (0.50) ALDH1A1LMNAKMT2AMCOLN3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060030718-A1 Cobalt-based catalysts for the cyclization of alkenes UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2006-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060030718-A1 Cobalt-based catalysts for the cyclization of alkenes PPOX, HCCS, ICOSLG ALDH1A1 3259/4885LMNA 1845/4885KMT2A 1748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.